|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Progressive Supranuclear Palsy | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Supranuclear Palsy, Progressive | |||||
| 3 | More general conditions related to this trial | ||||
| Basal Ganglia Diseases | |||||
| Brain Diseases | |||||
| Central Nervous System Diseases | |||||
| Cranial Nerve Diseases | |||||
| Eye Diseases | |||||
| Movement Disorders | |||||
| Nervous System Diseases | |||||
| Neurodegenerative Diseases | |||||
| Neurologic Manifestations | |||||
| Ocular Motility Disorders | |||||
| Ophthalmoplegia | |||||
| Paralysis | |||||
| Signs and Symptoms | |||||
| Tauopathies | |||||
| 4 | Sponsors listed in this trial | ||||
| University of Louisville | |||||
| National Institute on Aging (NIA) | |||||